Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy
Open Access
- 4 August 2011
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Hypertension Research
- Vol. 34 (12), 1302-1308
- https://doi.org/10.1038/hr.2011.127
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartanHypertension Research, 2010
- Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and NephropathyDiabetes, 2010
- Reduction of Renal Superoxide Dismutase in Progressive Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathyNephrology Dialysis Transplantation, 2008
- Deficiency of Endothelial Nitric-Oxide Synthase Confers Susceptibility to Diabetic Nephropathy in Nephropathy-Resistant Inbred MiceThe American Journal of Pathology, 2007
- Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiologyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Pioglitazone Prevents Hypertension and Reduces Oxidative Stress in Diet-Induced ObesityHypertension, 2004
- SUPEROXIDE RADICAL AND SUPEROXIDE DISMUTASESAnnual Review of Biochemistry, 1995
- Superoxide Radical and Superoxide DismutasesAnnual Review of Biochemistry, 1995